Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesDiseases of myoneural junction and muscleICD-10-CM g71-primary-disorders-of-muscles
    Ask Trek AI about this page

    ICD-10-CM Code For Primary Disorders Of Muscles: Group Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group G71 includes primary muscle disorders such as inherited muscular dystrophies, inflammatory myopathies, and other myopathies that primarily affect skeletal muscle function, strength, and structure. These ICD-10-CM diagnosis codes are used to document clinical presentations like progressive weakness, exercise intolerance, myalgias, and laboratory or biopsy-confirmed muscle pathology, capturing disease severity, organ involvement, or clinical complexity relevant to this group. Accurate coding within the ICD-10-CM G71 group supports proper claim adjudication, complete clinical documentation, and appropriate reimbursement.

    Customize your policy alerts

    Sign up for ICD-10-CM Code For Primary Disorders Of Muscles: Group Overview policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    ICD-10-CM G71: Primary Disorders Of Muscles Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group G71 covers primary disorders that primarily affect skeletal muscle function, such as inherited and acquired myopathies and muscular dystrophies. These conditions target the muscular system and can cause weakness, pain, and impaired mobility. Accurate coding is important for appropriate reimbursement and reflects the clinical complexity and resource needs of muscle disease care.

    Table of contents

    Progress1 / 6

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    When to Use

    Use a code from this group when the primary clinical problem is a disorder of skeletal muscle documented by clinical examination, laboratory testing, electromyography, or muscle biopsy. Select the specific code that best reflects the confirmed diagnosis, disease severity, and any documented complications or systemic involvement.

    ICD-10-CM Codes

    28 rows

    ICD-10-CM CodeDescription
    G71.00Muscular dystrophy, unspecified
    G71.01Duchenne or Becker muscular dystrophy
    G71.02Facioscapulohumeral muscular dystrophy
    G71.031Autosomal dominant limb girdle muscular dystrophy
    G71.032Autosomal recessive limb girdle muscular dystrophy due to calpain-3 dysfunction
    G71.033Limb girdle muscular dystrophy due to dysferlin dysfunction
    G71.0340Limb girdle muscular dystrophy due to sarcoglycan dysfunction, unspecified
    G71.0341Limb girdle muscular dystrophy due to alpha sarcoglycan dysfunction
    G71.0342Limb girdle muscular dystrophy due to beta sarcoglycan dysfunction
    G71.0349Limb girdle muscular dystrophy due to other sarcoglycan dysfunction
    G71.035Limb girdle muscular dystrophy due to anoctamin-5 dysfunction
    G71.036Limb girdle muscular dystrophy due to fukutin related protein dysfunction
    G71.038Other limb girdle muscular dystrophy
    G71.039Limb girdle muscular dystrophy, unspecified
    G71.09Other specified muscular dystrophies
    G71.11Myotonic muscular dystrophy
    G71.12Myotonia congenita
    G71.13Myotonic chondrodystrophy
    G71.14Drug induced myotonia
    G71.19Other specified myotonic disorders

    Showing 1–20 of 28

    DRG Codes

    3 rows

    DRG CodeDescription
    091Other Disorders of Nervous System with MCC
    092Other Disorders of Nervous System with CC
    093Other Disorders of Nervous System without CC/MCC

    Typical Clinical Scenarios

    • An adult presents to the emergency department with acute onset painless proximal muscle weakness developing over days to weeks, difficulty rising from a chair and climbing stairs, and elevated creatine kinase on labs. The clinician performs neurologic exam showing symmetric proximal weakness and orders myositis serologies and MRI; a primary inflammatory myopathy is suspected and a code from this muscle disorder group is assigned to capture the underlying myopathy. Typical codes: G71.31, G71.39
    • A middle‑aged patient in outpatient neurology has months of slowly progressive distal and proximal muscle weakness with family history of similar symptoms; genetic testing confirms a congenital or hereditary myopathy. The visit documents chronic neuromuscular weakness, baseline functional limitations, and ongoing management planning, so a hereditary primary muscle disorder code from the group is used for longitudinal care. Typical codes: G71.2, G71.1
    • A hospitalized patient with known systemic autoimmune disease develops steroid‑associated myopathy characterized by new proximal muscle weakness after prolonged glucocorticoid therapy; the admission is for worsening mobility and falls. The treating team documents that the muscle weakness is a complication of medication use and assigns a specific primary muscle disorder code to reflect the iatrogenic myopathy as a comorbidity affecting care. Typical codes: G71.0, G71.9

    Related Codes

    G70-MYASTHENIA-GRAVIS-AND-MYONEURAL-DISORDERS

    ICD-10-CM Code For Myasthenia Gravis And Other Myoneural Disorders: Group Overview

    G72-OTHER-AND-UNSPECIFIED-MYOPATHIES

    ICD-10-CM Code For Other And Unspecified Myopathies: Group Overview

    G73-DISORDERS-OF-MYONEURAL-JUNCTION-AND-MUSCLE

    ICD-10-CM Code For Disorders Of Myoneural Junction And Muscle In Diseases Classified Elsewhere: Group Overview

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.